Challenges in managing extensive brown tumors and renal stones in a young man with parathyroid carcinoma and single kidney: Case report

IF 0.2 Q4 ONCOLOGY
Syeda Sara Tajammul , Syed Furqan Hashmi , Zamzam Al Hashami , Laila Al Masaoudi , Sharjeel Usmani , Asma Naz Nadaf , Layth Mula-Hussain
{"title":"Challenges in managing extensive brown tumors and renal stones in a young man with parathyroid carcinoma and single kidney: Case report","authors":"Syeda Sara Tajammul ,&nbsp;Syed Furqan Hashmi ,&nbsp;Zamzam Al Hashami ,&nbsp;Laila Al Masaoudi ,&nbsp;Sharjeel Usmani ,&nbsp;Asma Naz Nadaf ,&nbsp;Layth Mula-Hussain","doi":"10.1016/j.cpccr.2024.100317","DOIUrl":null,"url":null,"abstract":"<div><p>Parathyroid carcinoma is one of the rare causes of primary hyperparathyroidism, comprising less than 1 % of its cases. Diagnosing parathyroid carcinoma typically requires a comprehensive evaluation using clinical, histological, and radiological methods. Primary hyperparathyroidism secondary to parathyroid carcinoma often presents with hypercalcemia, bone abnormalities, and renal stones. Brown tumours, a rare and late manifestation of hyperparathyroidism, signify the final stage in bone remodelling, and they can be easily mistaken for bony metastases, which highlights the importance of distinguishing between them to ensure appropriate management and avoid unnecessary treatment. Due to the rarity of parathyroid carcinoma, there is currently no standardized staging system or specific guidelines for its management. Consequently, the involvement of a multidisciplinary team has become crucial in addressing this disease. Surgery is considered the primary treatment approach, while the role of adjuvant radiotherapy and chemotherapy remains controversial. With ongoing research, the treatment landscape for parathyroid carcinoma may evolve, offering new hope for improved outcomes and quality of life for affected individuals.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000401/pdfft?md5=1cafb0bcb3d935da3042c1c835ac3d90&pid=1-s2.0-S2666621924000401-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current problems in cancer. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666621924000401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Parathyroid carcinoma is one of the rare causes of primary hyperparathyroidism, comprising less than 1 % of its cases. Diagnosing parathyroid carcinoma typically requires a comprehensive evaluation using clinical, histological, and radiological methods. Primary hyperparathyroidism secondary to parathyroid carcinoma often presents with hypercalcemia, bone abnormalities, and renal stones. Brown tumours, a rare and late manifestation of hyperparathyroidism, signify the final stage in bone remodelling, and they can be easily mistaken for bony metastases, which highlights the importance of distinguishing between them to ensure appropriate management and avoid unnecessary treatment. Due to the rarity of parathyroid carcinoma, there is currently no standardized staging system or specific guidelines for its management. Consequently, the involvement of a multidisciplinary team has become crucial in addressing this disease. Surgery is considered the primary treatment approach, while the role of adjuvant radiotherapy and chemotherapy remains controversial. With ongoing research, the treatment landscape for parathyroid carcinoma may evolve, offering new hope for improved outcomes and quality of life for affected individuals.

治疗一名患有甲状旁腺癌和单肾的年轻人的广泛性褐色肿瘤和肾结石的挑战:病例报告
甲状旁腺癌是原发性甲状旁腺功能亢进症的罕见病因之一,占原发性甲状旁腺功能亢进症病例的不到1%。诊断甲状旁腺癌通常需要采用临床、组织学和放射学方法进行综合评估。继发于甲状旁腺癌的原发性甲状旁腺功能亢进通常表现为高钙血症、骨异常和肾结石。褐色瘤是甲状旁腺功能亢进症的一种罕见晚期表现,标志着骨重塑的最后阶段,很容易被误认为是骨转移瘤,这就凸显了区分两者的重要性,以确保进行适当的治疗,避免不必要的治疗。由于甲状旁腺癌非常罕见,目前还没有标准化的分期系统或具体的治疗指南。因此,多学科团队的参与对治疗这种疾病至关重要。手术被认为是主要的治疗方法,而辅助放疗和化疗的作用仍存在争议。随着研究的不断深入,甲状旁腺癌的治疗前景可能会发生变化,为改善患者的治疗效果和生活质量带来新的希望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
审稿时长
96 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信